BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Queensland Health
Johnson and Johnson
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,404,216

« Back to Dashboard

Summary for Patent: 4,404,216

Title: Antifungal 1,3-bis-triazolyl-2-propanol derivative
Abstract:2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its pharmaceutically acceptable acid addition salts are disclosed. This particular bis-triazole derivative and its aforesaid salts are useful for treating fungal infections in animals, including humans. Methods for preparing these compounds from known starting materials are provided.
Inventor(s): Richardson; Kenneth (Canterbury, GB2)
Assignee: Pfizer Inc. (New York, NY)
Application Number:06/383,866
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,404,216

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8117379Jun 06, 1981
United Kingdom8131370Oct 17, 1981
United Kingdom8206329Mar 04, 1982

International Patent Family for Patent: 4,404,216

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland53144► Subscribe
Israel65963► Subscribe
Hungary189143► Subscribe
Ireland821285► Subscribe
CroatiaP930368► Subscribe
Hong Kong8488► Subscribe
Greece76491► Subscribe
Finland71134► Subscribe
United Kingdom2099818► Subscribe
Finland822005► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Express Scripts
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: